FIGURE

Figure 5

ID
ZDB-FIG-200517-16
Publication
van den Bos et al., 2020 - Early Life Glucocorticoid Exposure Modulates Immune Function in Zebrafish (Danio rerio) Larvae
Other Figures
All Figure Page
Back to All Figure Page
Figure 5

(A) Transcript abundance (relative normalized expression; mean+SEM) of cldn5a following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD following a significant treatment effect for this time-point). Note: control-treated subjects showed no significant change over time: F(3, 12) = 2.009, ns. (B) Transcript abundance (relative normalized expression; mean + SEM) of cldn2 following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Note: control-treated subjects showed an increased expression at 3 h: F(3, 12) = 13.253, p < 0.001; Tukey HSD. (C) Transcript abundance (relative normalized expression; mean + SEM) of oclnb following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD following a significant treatment effect for this time-point). Note: control-treated subjects showed no significant change over time: F(3, 12) = 0.562, ns.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Immunol